Exam 4 (Final) Flashcards
- evidence of substantial decline in one or more of the cognitive domains
- deficits are sufficient to interfere with independence
- test performance of >2 SDs below the mean
- problems cannot be attributed to another factor e.g. depression
Major neurocognitive disorder
What is the name of the protein structures contained in neurites?
microtubules
causes tau to unbind and form twisted filaments
hyperphosphorylation
Treatment for Alzheimer’s disease (2)
- medication- act on neurotransmitter systems
- behavioral interventions- SLP
- relatively rare
- neuropathology
- tau deposition in brain stem, including substantia nigra
- hypothesized causal agents include viruses, environmental exposures (via waer, air) random gene mutations, and free radicals
- symptoms
- similar to but different from Parkinson’s
- problems with balance
- cognitive changing, bradycognition, memory
Progressive supranuclear palsy (PSP)
- cytoskeleton of the neurites
- also transport biomolecules (proteins, lipids, sugars) from the cell body to the axon end terminal
- MAP proteins bind to and stabilize the microtubles
- Tau is the axon’s MAP proteins
Microtubules
Where does early cell loss often begin with Alzheimer’s?
medial temporal lobe
- type of vascular dementia
- inherited
- mutation of Notch3 gene
- first symptoms can appear between 20 and 40 years
- often undiagnosed
CADASIL
- modest decline in memory attention, language, orientation and/or perception
- noted by the individual, knowledgeable informant or the clinician
- test performance 1 to 2 SDs below the mean
- deficits do not interfere with independence
- problems cannot be attributed to antoher factor, e.g. depression
Minor neurocognitive disorder
facility of a person in conversation; includes abilities such as turn-taking, type of initiation, and type of response
Conversational analysis
- not everyone with PD will develop dementia, however majority will
- great individual variation in the time from initial diagnosis of PD to the development of dementia
Synucleinopathies- Parkinson’s Disease Dementia
AD
no obvious signs or symptoms
preclinical stage
- prevalence estimates vary from 2nd to 4th most common
- neuropathology
- several forms of FTD
- some forms of tauopathies
- some people with FTD have mutant gene for tau
- other forms of FTD involve mutant genes for other proteins- not tauopathies
- initially affects frontal and/or temporal obes
- two main types of FTD
- behavioral varient
- primary progreessive aphasia
- diagnosis
- imaging
- behavioral testing
- treatment
- medication
- antidepressants, antipsychotics
- Namenda for memory
- other drugs for memory used with AD may exacerbate symptoms
- speech-language therapy for the language varient
- medication
Tauopathies- frontotemoporal degeneration (FTD)
- no specific gene that causes this
- certain alleles (forms) of the apolipoprotein E (APOE) gene increase risk for developing this
- presence of e4 allele increases risk
Late onset Alzheimer’s
2 new terms that replace dementia
- minor neurocognitive disorder
- major neurocognitive disorder
True or false
a definitive diagnosis of Alzheimer’s disease can only be made through autopsy
true
what is the most common type of dementia?
Alzheimer’s Disease
- most cases are familial Alzheimer’s disease (FAD)
- linked to a single gene mutation on chromososmes 21, 14, and 1
- gene mutation leads to cleaving problems of APP
- individuals with the mutation will develop AD
early onset Alzheimer’s disease
- AD stage
- inability to communicate
- inability to self feed
- swallowing problems
- lack of bowel and bladder control
severe Alzheimer’s disease
amount, quality, and efficiency of the discourse. Measures: correct information units; correct information units/minute; propositions
Informational content analysis
- a common late onset disease
- tau deposits called argyrophillic grains found in limbic regions, including hippocampus
- signs and symptoms indistinguishable from late onset AD
Argyrophilic grain disease
- Prion- misfolded form of PrPc protein (PrPsc)
- misfolded form was discovered before the normal form
- normal form plays a role in myelin formation and iron metabolism
- prions appear to cause the normal PrPc to misfold
Prion disease
- relatively rare
- underlying neuropathology
- tau inclusions in neurons and glia
- may be tangles similar to AD
- swollen neurons
- affects frontoparietal regions and substantia nigra with relative sparing of temporal and occipital lobes
- signs and symptoms
- relatively young onset
- initial symptoms- movement disorder or cognitive problems
- initially, movement disorder affects on side of the body
- limb rigidity, or akinesia, limb myoclonus, limb dystonia
- orobuccal or limb apraxia
- as the disease progresses, both sides affected
- cognitive problems include memory loss, progressive difficulty with language, behavioral problems
- Slow progression 6-8 years
- diagnosis
- no definitive diagnosis until autopsy
- imaging, behavioral testing (including SLP)
- tx with levadopa (L-DOPA)- people with CBD do not respond
- Treatment
- medications to control movement problems
- SLP, PT, OT
Tauopathies- Corticobasal degeneration
- type of vascular dementia
- caused by multiple small strokes
- more likely when the strokes occur bilaterally
- can be caused by single severe stroke
multi infarct dementia